CD8A and hepatocellular carcinoma: sFGL2 protein secreted by LX2 cells suppressed CD8+ T cell proliferation of HCC patients in a dose-dependent manner in vitro, and blockade of sFGL2 with antibody enhanced the proliferation of CD8+ T cells significantly [102].